Is Allergan’s Botox on the Block? Does this Explain Johnson & Johnson’s Decision to Dump PurTox?
April 24, 2014 Related Story Valeant Pharmaceuticals International Inc. made an unsolicited $47 billion bid for Botox-maker Allergan Inc. That seems odd, doesn't it? Was it really unsolicited or was it strategic? This may explain why Johnson & Johnson's Mentor dumped PurTox earlier last week and perhaps...